The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASTRO 2022 | Potential role of radiotherapy for liver cancer
Laura A. Dawson, MD, FASTRO, Princess Margaret Cancer Center, Toronto, Canada, discusses the use of radiotherapy for liver cancer treatment, particularly for patients with unresectable HCC, and highlights the further research required to uncover its potential. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
